Replimune Group Analyst Price Targets - Benzinga

Replimune Group Inc

REPLNASDAQ

Trade with Public

Trade with Public

$13.04

-0.16-1.21%

最終更新: Oct 8, 4:42 PM

$13.04

-0.16-1.21%

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

Replimune Group Analyst Price Targets

Wall Street analyst price targets and consensus rating for Replimune Group (REPL).

Price Target Range — 11 Quarters

Analyst Consensus — 9 Analysts

6Buy

2Hold

1Sell

Consensus RatingOutperform# Analysts9Avg. Consensus PT$13Upside to Avg. PT-0.3%

Rating Trend — Last 9 Months

Recent Analyst Actions

すべての評価を見る →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 26, 2026	JP Morgan	Anupam Rama	PT Raise	Overweight	$20→$21
Aug 7, 2026	JP Morgan	Anupam Rama	PT Raise	Overweight	$17→$20
Aug 7, 2026	Wedbush	Robert Driscoll	Upgrade	Neutral→Outperform	$12→$19
Aug 4, 2026	Leerink Partners	Jonathan Chang	Upgrade	Market Perform→Outperform	$11→$17
Jul 31, 2026	Cantor Fitzgerald	Li Watsek	Upgrade	Neutral→Overweight	—
Jul 31, 2026	Wedbush	Robert Driscoll	PT Raise	Neutral	$9→$12
Jun 30, 2026	Wedbush	Robert Driscoll	PT Raise	Neutral	$6→$9
Jun 26, 2026	JP Morgan	Anupam Rama	Upgrade	Neutral→Overweight	$8→$17
Jun 1, 2026	Wedbush	Robert Driscoll	PT Raise	Neutral	$2→$6
May 29, 2026	JP Morgan	Anupam Rama	Upgrade	Underweight→Neutral	$8
Apr 13, 2026	Cantor Fitzgerald	Li Watsek	Downgrade	Overweight→Neutral	—
Apr 13, 2026	Leerink Partners	Jonathan Chang	Downgrade	Outperform→Market Perform	$11→$2
Apr 13, 2026	JP Morgan	Anupam Rama	Downgrade	Neutral→Underweight	—
Apr 13, 2026	Wedbush	Robert Driscoll	Downgrade	Outperform→Neutral	$19→$2
Apr 13, 2026	Jefferies	Roger Song	Downgrade	Buy→Hold	$13→$2
Apr 13, 2026	HC Wainwright & Co.	Robert Burns	Downgrade	Buy→Sell	—
Feb 5, 2026	Piper Sandler	Allison Bratzel	PT Raise	Overweight	$13→$14
Feb 4, 2026	Wedbush	Robert Driscoll	PT Raise	Outperform	$18→$19
Nov 3, 2025	BMO Capital	Evan David Seigerman	Upgrade	Underperform→Market Perform	$2→$11
Oct 27, 2025	HC Wainwright & Co.	Robert Burns	Upgrade	Neutral→Buy	$12

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
JP Morgan Maintains Overweight on Replimune Group, Raises Price Target to $21

JP Morgan analyst Anupam Rama maintains Replimune Group (NASDAQ:REPL) with a Overweight and raises the price target from $20 to $21.

Benzinga Newsdesk

PRO
Wedbush Upgrades Replimune Group to Outperform, Raises Price Target to $19

Wedbush analyst Robert Driscoll upgrades Replimune Group (NASDAQ:REPL) from Neutral to Outperform and raises the price target from $12 to $19.

Benzinga Newsdesk

This Palantir Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday

Analysts upgraded Replimune, Madrigal, BBB Foods, Palantir, and Fomento Economico. See other opinions and price targets for these stocks.

Avi Kapoor

PRO
Leerink Partners Upgrades Replimune Group to Outperform, Raises Price Target to $17

Leerink Partners analyst Jonathan Chang upgrades Replimune Group (NASDAQ:REPL) from Market Perform to Outperform and raises the price target from $11 to $17.

Benzinga Newsdesk

PRO
Wedbush Maintains Neutral on Replimune Group, Raises Price Target to $12

Wedbush analyst Robert Driscoll maintains Replimune Group (NASDAQ:REPL) with a Neutral and raises the price target from $9 to $12.

Benzinga Newsdesk

This Plexus Analyst Turns Bullish; Here Are Top 4 Upgrades For Friday

Top Wall Street analysts upgraded IP, AXTI, REPL, and PLXS stocks with higher price targets. See what other analysts think about these stocks.

Avi Kapoor